Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2771-2784
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Figure 4
Figure 4 S-plots following (A) PCA, (B) PLS, and (C) OPLS analyses with (A1, B1 and C1) electrospray ionization (ESI+) and without (A2, B2 and C2) electrospray ionization (ESI-) in the non-alcoholic fatty liver disease and control groups. PCA: Principal component analysis; NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease.